Not Yet RecruitingNot Applicable

NMT EasyFit Sensor and Cable

United States30 participantsStarted 2026-02-01

Plain-language summary

The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Study subject (male or female) is age 18 years or older (≥18 years).
✓. Study subject must have the ability to understand and provide written informed consent.
✓. Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.
✓. Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.

Exclusion criteria

✕. Are known to be pregnant.
✕. Are breastfeeding.
✕. Suffering from an infection(s) that requires isolation.
✕. Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject.
✕. Subjects requiring rapid sequence induction
✕. Subjects expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study.
✕. Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules).
✕. NMT ElectroSensor placed on the foot/ankle

What they're measuring

Collection of End User Feedback Surveys

Timeframe: Up to 24 hours

Trial details

NCT IDNCT07394140

SponsorGE Healthcare

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-05-31

Contact for this trial

Melissa McCabe, MD

909-558-4475 mmccabe@llu.edu

View on ClinicalTrials.gov More Neuromuscular Blockade Monitoring trials